Literature DB >> 17308240

Paroxetine-induced bruxism effectively treated with tandospirone.

Yasuhiro Kishi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17308240     DOI: 10.1176/jnp.2007.19.1.90

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


× No keyword cloud information.
  7 in total

1.  Sleep bruxism frequency and platelet serotonin transporter activities in young adult subjects.

Authors:  Hajime Minakuchi; Chiharu Sogawa; Haruna Miki; Emilio S Hara; Kenji Maekawa; Norio Sogawa; Shigeo Kitayama; Yoshizo Matsuka; Glenn Thomas Clark; Takuo Kuboki
Journal:  Sleep Breath       Date:  2015-11-02       Impact factor: 2.816

Review 2.  SSRI-associated bruxism: A systematic review of published case reports.

Authors:  Andrew R Garrett; Jason S Hawley
Journal:  Neurol Clin Pract       Date:  2018-04

3.  Paroxetine-induced severe sleep bruxism successfully treated with buspirone.

Authors:  Aysel Milanlioglu
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

4.  Current Treatments of Bruxism.

Authors:  Marc Guaita; Birgit Högl
Journal:  Curr Treat Options Neurol       Date:  2016-02       Impact factor: 3.598

Review 5.  Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms.

Authors:  Xuefei Huang; Jing Yang; Sijin Yang; Shousong Cao; Dalian Qin; Ya Zhou; Xiaoli Li; Yun Ye; Jianming Wu
Journal:  Oncotarget       Date:  2017-10-27

6.  Sertraline induced mandibular dystonia and bruxism.

Authors:  N A Uvais; V S Sreeraj; S V Sathish Kumar
Journal:  J Family Med Prim Care       Date:  2016 Oct-Dec

7.  Long-term follow-up of a patient with venlafaxine-induced diurnal bruxism treated with an occlusal splint: A case report.

Authors:  Jia-Min Chen; Ying Yan
Journal:  World J Clin Cases       Date:  2019-02-26       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.